Wolverine Trading’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-28,500
| Closed | -$2.42M | – | 5702 |
|
|
2019
Q4 | $2.42M | Sell |
28,500
-29,000
| -50% | -$1.93M | 0.01% | 1683 |
|
|
2019
Q3 | $2.77M | Buy |
+57,500
| New | +$2.29M | 0.01% | 1212 |
|
|
2019
Q2 | – | Sell |
-82,400
| Closed | -$2.3M | – | 5481 |
|
|
2019
Q1 | $2.3M | Buy |
82,400
+27,200
| +49% | +$641K | 0.01% | 1412 |
|
|
2018
Q4 | $1.04M | Sell |
55,200
-4,100
| -7% | -$95.4K | ﹤0.01% | 1926 |
|
|
2018
Q3 | $1.77M | Buy |
59,300
+51,600
| +670% | +$1.94M | ﹤0.01% | 1788 |
|
|
2018
Q2 | $254K | Hold |
7,700
| – | – | ﹤0.01% | 4030 |
|
|
2018
Q1 | $254K | Sell |
7,700
-10,500
| -58% | -$328K | ﹤0.01% | 4030 |
|
|
2017
Q4 | $498K | Sell |
18,200
-20,700
| -53% | -$638K | ﹤0.01% | 3002 |
|
|
2017
Q3 | $1.44M | Sell |
38,900
-3,600
| -8% | -$133K | 0.01% | 1580 |
|
|
2017
Q2 | $1.65M | Sell |
42,500
-34,300
| -45% | -$1.53M | 0.01% | 1364 |
|
|
2017
Q1 | $3.77M | Buy |
76,800
+58,700
| +324% | +$2.68M | 0.02% | 797 |
|
|
2016
Q4 | $614K | Sell |
18,100
-10,100
| -36% | -$358K | ﹤0.01% | 2388 |
|
|
2016
Q3 | $1.07M | Buy |
28,200
+9,400
| +50% | +$354K | 0.01% | 1792 |
|
|
2016
Q2 | $635K | Buy |
+18,800
| New | +$663K | ﹤0.01% | 1992 |
|
Other funds holding MDCO
Wolverine Trading's MDCO Position: Q1 2020 in Review
Wolverine Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 50,660 shares — an estimated $4.3M sold.
Wolverine Trading first reported a position in MDCO in Q2 2016 and held it in 9 quarters. The position peaked at $4.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Wolverine Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Wolverine Trading sold 50,660 Medicines Co shares in Q1 2020, an estimated $4.3M.
- Wolverine Trading first reported a position in Medicines Co in Q2 2016 and held it in 9 quarters.
- Wolverine Trading's Medicines Co position peaked at $4.3M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.